TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 137 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $35,525,000 | +1125.0% | 2,500,000 | +400.0% | 1.37% | +626.6% |
| Q3 2018 | $2,900,000 | -15.7% | 500,000 | -12.8% | 0.19% | -26.0% |
| Q2 2018 | $3,439,000 | -16.7% | 573,208 | 0.0% | 0.25% | -17.5% |
| Q1 2018 | $4,127,000 | -5.8% | 573,208 | -4.5% | 0.31% | -32.8% |
| Q4 2017 | $4,380,000 | +41.7% | 600,000 | 0.0% | 0.46% | -16.1% |
| Q3 2017 | $3,090,000 | +17.0% | 600,000 | 0.0% | 0.55% | +24.7% |
| Q2 2017 | $2,640,000 | – | 600,000 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 701,138 | $4,067,000 | 0.67% |
| Matrix Capital Management Company, LP | 2,288,560 | $13,274,000 | 0.33% |
| NEA Management Company, LLC | 1,250,000 | $7,250,000 | 0.31% |
| Stanley-Laman Group, Ltd. | 139,403 | $809,000 | 0.20% |
| Cormorant Asset Management, LP | 500,000 | $2,900,000 | 0.19% |
| Tekla Capital Management LLC | 468,399 | $2,717,000 | 0.10% |
| Wealth Alliance Advisory Group, LLC | 21,800 | $126,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $1,007,000 | 0.03% |
| Artal Group S.A. | 150,000 | $870,000 | 0.02% |
| Baker Brothers Advisors | 505,262 | $2,931,000 | 0.02% |